administration of antihistamines and the basal corticosteroid therapy which many patients have received.
The frequency ofreactions is difficult to predict, but shows a rough correlation with the level of heterophile antibodies in the patient. Recently more attempts have been made to make the patient tolerant to the xenogeneic proteins before starting the course of ALG, since it has been found that the reactions apparently do not occur to the contaminating xenogeneic proteins alone, but may be caused by the immunoglobulin which must be in the preparation.
The frequency of reactions with long courses of ALG has often led to termination of the course, or to the use of ALG from other species, when sensitivity to one species has occurred.
Side-effects ofImmunosuppression
The clinical use of ALG has been largely in organ transplantation, where its efficacy at preventing cellular immunity looked very promising. The fact that the late effects of transplantation immunity do not appear to be due to cellular immunity, but rather to the presence of humoral antibody has meant that ALG has not been used alone in organ transplantation in man. In animals, treatment with ALS alone has resulted in the development of lesions in the glomerular capillaries of renal transplants (Pichlmayr et al. 1968 ). Thus the complications of immunosuppression in ALGtreated patients are a result of combined therapy. It is known that infections with 'opportunist invaders' are common where the standard combination of azathioprine and steroids is used, and that steroid treatment alone may result in many of these infections. Specific suppression, or failure of cellular immunity in man or animals, appears to be associated with a particular susceptibility to virus infections. These are common with the use of azathioprine and steroids. Several centres have reported trouble with herpes simplex virus when ALG is used in addition.
Azathioprine is known to increase the incidence of neoplasia in animals (Casey 1968 ). This agent, although effective in suppressing cellular immunity, also affects humoral immune responses. ALS has been shown to increase the incidence of lymphomas in mice. It might be thought that interference with the ability to control virus infections and hence murine viral oncogenesis was the explanation of this. Recently, however, it has been reported that the latent period was shortened, and the incidence of tumours increased, by ALS treatment of animals in' which chemical carcinogenesis occurred (Cerilli & Treat 1969) .
In man tumours have occurred in patients treated with ALS or ALG, but they are of course known also to occur in patients treated with azathioprine and steroids (McKhann 1969) . It is not at present possible to say whether the incidence is altered by the addition of ALG. If ALG is used alone to treat diseases other than transplantation immunity, a better assessment of the risk will be available. Azathioprine, although carcinogenic, possesses an antitumour action; it may not be as effective in producing measurable oncogenesis as a purely immunosuppressive agent such as ALG.
It can be seen that some of the problems of studying the specific side-effects ofALG in clinical use are complicated by its use in combined therapy. This is necessarily so in organ transplantation. From its possible use in immune diseases of a purely cellular immune character, it will be possible to state more certainly the nature of these risks. In the meantime the use of material with as little nonspecific antibody as possible, in recipients tolerant to xenogeneic protein, will do much to diminish the obvious specific side-effects.
Professor H I Winner, Dr K D Bagshawe, Dr J C Coleman and Dr Anne Gerken (Department ofMicrobiology, Charing Cross Hospital Medical School, London WC2N4DW)
Microbiological Aspects of Cytotoxic Drug Therapy
The microbiological problem is that of keeping patients as free from infection as possible.
Methods ofIsolation
Various methods of isolation are available, such as specially built units or plastic isolators. Whatever method is adopted, a regime has to be devised for the surveillance of patients, staff and environment. Every detail of the regime should be made clear to all concerned and rigidly enforced even though the rationale of some of the measures is likely, in the present state of our knowledge, to be dubious and their efficacy unproved or unprovable. All those concerned with surveillance must be acquainted with and trained in every detail of the regime. At Charing Cross Hospital, Fulham, an ultraclean unit for the treatment of these patients was opened in 1963 under the direction of Dr K D Bagshawe, who has described it (Bagshawe 1964) . Andrews & Bagshawe (1966) have given an account of staphylococcal infections in the first years of its opening. The unit was primarily intended for long-stay patients suffering from choriocarcinoma but other malignant diseases including leukeemia have also been treated. Initially it had 8 beds but the unit was later extended. It now has 13 beds and is always fully occupied. This paper deals with the control of infection in the unit from January 1967 to October 1969.
The unit is maintained under a strict discipline of hygiene and environmental control, which was initially worked out by those concerned and which has since been modified in minor ways.I
The demand for treatment has been such that by no means all patients admitted for treatment could be taken directly into the ultra-clean unit. A number had to be treated in open 'ordinary' hospital wards at Fulham Hospital and some were admitted to the ordinary wards first to await a bed becoming available in the ultra-clean unit, to which they were then transferred. A very few, in fact 3, started in the ultra-clean unit and then went to the ordinary ward (see Table 1 ).
We can therefore make a direct comparison between the fate of patients admitted into the ultra-clean unit and of those admitted into ordinary wards. However, the comparison is not exact; the tendency was to send the most ill patients into the ultra-clean unit instead of into the ordinary wards. This is illustrated by the numbers of deaths "Details of the regime may be obtained form Professor H I Winner, Bacteriology Department, Fulham Hospital, London W6 from non-infective causes, which was 29 in the ultra-clean unit and 6 in the ordinary wards. Also, long-term infusion therapy was generally possible only in the ultra-clean unit. This comparison is therefore weighted in favour of the ordinary wards.
In the ultra-clean unit the average length of stay was 113 days and the longest stay was 436 days; in the ordinary wards the average stay was 103 days and the longest 366 days.
Bacteriological comparison of the ultra-clean and ordinary wards is shown in Table 2 , which gives the results of settle plate exposures at comparable places in August 1967.
The results of slit sampling analyses of the air in the ultra-clean unit have usually shown counts of less than 10 colonies per ft3 (<400 per m3) of air.
Our definition of serious infections in the unit has been arbitrary, and comprised the following: Wound infections, chest infections, urinary infections with raised WBC and more than 100,000 organisms per ml, infected catheter sites, infected drainage tubes, skin lesions, viral isolates, salmonella and shigella infections, positive blood cultures.
Serious infections, as defined above, were encountered in 16 of the 59 patients who spent some time in the ultra-clean unit, and in 22 of the 62 patients who spent some time in the ordinary wards. A number of these patients were infected on admission to hospital; excluding these, there were the following numbers who acquired infections in the hospital: in the ultra-clean ward 4 out of 59; in the ordinary wards 10 out of 62.
However, these figures are not comparable.
Patients who spent some time in both wards and who became infected, might have become infected in either ward; it is impossible to assess the incubation periods of any of the infections. Such patients must therefore be excluded. The numbers of patients who were undoubtedly infected in each type of ward environment were: in the ultra-clean ward, 2 out of 39; in the ordinary ward, 7 out of 42.
The relation of these numbers of infections to the total numbers of exposure days is shown in Table 3 . This gives what is probably the most valid comparison available between the results obtained in the two types of environment.
The 2 infections acquired in the ultra-clean unit were both urinary. The 7 infections in the ordin- ary ward were: 2 mixed chest infections, 2 urinary infections, 1 disseminated pseudomonas infection, and 2 bloodstream infections, one with Ps. aeruginosa and one with Candida albicans. Table 4 shows the rates of acquisition of various microbes by patients in the two types of ward environment.
Costs ofthe Unit A very relevant factor in discussing bacteriological surveillance of such complexity is the cost, which may be considered under a number of headings such as the cost of planning, building, and running the unit, the cost of additional specially trained staff required, and the cost of bacteriological and other investigations.
The capital cost per bed in this unit was approximately £5,500. The principal recurrent expenditure is on nurses' salaries. The nursing establishment is 22 for the 13 patients. There are additional but comparatively small costs attributable to air-conditioning plant and to central sterile supplies. So far as medical staff are concerned, the unit is part of a research unit, but the clinical team consisting of one consultant, one senior registrar and two senior house officers would seem to be the minimum to provide roundthe-clock care for 13 ultra-clean ward patients and a similar number of chemotherapy patients in open wards.
Although some of the running costs are attributable to the bacteriological surveillance of the ultra-clean unit, the same patients undergoing treatment in ordinary wards also require aboveaverage nursing care and bacteriological surveillance. Thus the additional running costs relate mainly to the nature of the clinical work undertaken and only to a limited extent to the operation ofthe ultra-clean unit itself.
The cost of laboratory investigations may be assessed by consideration of the work load related to the unit and ordinary ward chemotherapy patients. The load on the bacteriology laboratory in 1968 is shown in Table 5. The 10,000 or so mixed specimens per year require the services, over and above the other laboratory staff, of two technicians, two part-time registrars, and approximately one weekly consultant session.
There is also a'considerable additional load on the hematology laboratory.
It is essential, before any commitment of this kind is undertaken, that the extra staff requirements, and the likely additional load of laboratory work, are properly assessed and provided for in advance.
